AHR and neoplasm: Deletion of AhR in TAMs or pharmacologic inhibition of AhR reduced PDAC tumor growth, improved efficacy of immune checkpoint blockade, and increased intratumoral frequencies of IFN‐γ+ CD8+ T cells [39].